Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
SAGE

Sage Therapeutics

$169.57

-2.98 (-1.73%)

16:43
04/19/18
04/19
16:43
04/19/18
16:43
Hot Stocks
Sage Therapeutics director Kevin Starr sells 59,000 shares »

In a filing out after the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 30

    May

VRX

Valeant

$17.13

-0.31 (-1.78%)

11:00
04/19/18
04/19
11:00
04/19/18
11:00
Options
5K Valeant Apr 17 - May 18 call spreads trade at 41c »

5K Valeant Apr 17 - May…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

  • 13

    May

  • 18

    Jun

  • 27

    Aug

LGND

Ligand

$167.46

-2.85 (-1.67%)

, NVS

Novartis

$79.64

-2.08 (-2.55%)

10:30
04/19/18
04/19
10:30
04/19/18
10:30
Recommendations
Ligand, Novartis, Retrophin analyst commentary at H.C. Wainwright »

H.C. Wainwright…

LGND

Ligand

$167.46

-2.85 (-1.67%)

NVS

Novartis

$79.64

-2.08 (-2.55%)

RTRX

Retrophin

$26.71

0.26 (0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Apr

  • 23

    Apr

  • 01

    May

  • 03

    May

  • 10

    May

  • 17

    May

  • 21

    May

  • 29

    May

  • 05

    Jun

VBIV

VBI Vaccines

$3.45

0.19 (5.83%)

08:09
04/19/18
04/19
08:09
04/19/18
08:09
Hot Stocks
VBI Vaccines completes enrollment in PROTECT Phase 3 clinical study »

VBI Vaccines announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVXS

AveXis

$210.20

-1.96 (-0.92%)

08:08
04/19/18
04/19
08:08
04/19/18
08:08
Hot Stocks
AveXis to present AVXS-101 data at annual AAN meeting »

AveXis announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

AGLE

Aeglea BioTherapeutics

$8.46

-0.94 (-10.00%)

06:08
04/19/18
04/19
06:08
04/19/18
06:08
Syndicate
Aeglea BioTherapeutics 4.5M share Secondary priced at $8.00 »

Evercore ISI and BMO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 19

    Apr

NEOS

Neos Therapeutics

04:55
04/19/18
04/19
04:55
04/19/18
04:55
Conference/Events
Neos Therapeutics management to meet with Wells Fargo »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

COO

Cooper Companies

$227.08

-0.27 (-0.12%)

04:55
04/19/18
04/19
04:55
04/19/18
04:55
Conference/Events
Cooper Companies management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Apr

Yesterday
RIGL

Rigel Pharmaceuticals

$3.87

-0.24 (-5.84%)

16:39
04/18/18
04/18
16:39
04/18/18
16:39
Syndicate
Rigel Pharmaceuticals announces 15M share common stock offering »

Rigel Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Jun

FLXN

Flexion

$26.36

-0.12 (-0.45%)

16:28
04/18/18
04/18
16:28
04/18/18
16:28
Hot Stocks
Flexion publishes Phase 3 Zilretta results that met primary endpoint »

Flexion announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

  • 25

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.